Viral Infections
11
3
5
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (11)
Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010
T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell Transplantation
Early Discontinuation of Antibiotic Therapy in Elderly Patients Hospitalized for a Viral Infection
Respiratory Infections in Young Children
AI-Guided Proteomic Biomarker Panel for Differentiating Bacterial and Viral Infections in Acute Febrile Illness
The AcCREDiT 2 Study
Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections
Emergency PWAS in Respiratory Infectious Disease
Influenza in People With Normal and Weakened Immune Systems
Specimens From Normal Controls
Virus Surveillance in Pediatric Solid Organ Transplant Recipients